Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia

References

1. ↵
   1. Workowski KA,
   2. Berman S

   (2010) Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59:1–110.

   OpenUrlPubMed
2. 1. Donahue JG,
   2. Nelson KE,
   3. Mu-oz A,
   4. Vlahov D,
   5. Rennie LL,
   6. Taylor EL,
   7. et al.

   (1991) Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 134:1206–1211.

   OpenUrlPubMedWeb of Science
3. ↵
   1. Coppola RC,
   2. Manconi PE,
   3. Piro R,
   4. Di Martino ML,
   5. Masia G

   (1994) HCV, HIV, HBV and HDV infections in intravenous drug addicts. Eur J Epidemiol 10:279–283.

   OpenUrlPubMed
4. ↵
   1. Van Beek I,
   2. Buckley R,
   3. Stewart M,
   4. MacDonald M,
   5. Kaldor J

   (1994) Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med 70:321–324.

   OpenUrlPubMedWeb of Science
5. ↵
   1. Van Ameijden EJ,
   2. Van den Hoek JA,
   3. Mientjes GH,
   4. Coutinho RA

   (1993) A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 9:255–262.

   OpenUrlCrossRefPubMedWeb of Science
6. 1. Alter MJ,
   2. Moyer LA

   (1998) The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 18(Suppl 1):S6–S10.

   OpenUrlCrossRefPubMed
7. ↵
   1. Koester S,
   2. Booth RE,
   3. Wiebel W

   (1990) The risk of HIV transmission from sharing water, drug mixing containers and cotton filters among intravenous drug users. Int J Drug Policy 1:28–30.

   OpenUrl
8. ↵
   1. Hall HI,
   2. Song R,
   3. Rhodes P,
   4. Prejean J,
   5. An Q,
   6. Lee LM,
   7. et al.

   (2008) Estimation of HIV incidence in the United States. JAMA 300:520–529.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Prejean J,
   2. Song R,
   3. Hernandez A,
   4. Ziebell R,
   5. Green T,
   6. Walker F,
   7. et al.

   (2011) Estimated HIV incidence in the United States, 2006-2009. PLoS One 6:e17502.

   OpenUrlCrossRefPubMed
10. ↵
    1. Daniels D,
    2. Grytdal S,
    3. Wasley

    (2009) Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 58(SS-3):1–27.

    OpenUrlPubMed
11. ↵
    1. Njoh J,
    2. Zimmo S

    (1997) The prevalence of human immunodeficiency virus among drug-dependent patients in Jeddah, Saudi Arabia. J Subst Abuse Treat 14:487–488.

    OpenUrlPubMed
12. ↵
    1. Njoh J,
    2. Zimmo S

    (1997) Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia. East Afr Med J 74:89–91.

    OpenUrlPubMed
13. ↵
    1. Njoh J

    (1995) Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia. East Afr Med J 72:490–491.

    OpenUrlPubMed
14. ↵
    1. Alzahrani AJ,
    2. Dela Cruz DM,
    3. Obeid OE,
    4. Bukhari HA,
    5. Al-Qahtani AA,
    6. Al-Ahdal MN

    (2009) Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia. J Med Virol 81:1343–1347.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Mazroa MA,
    2. Kabbash IA,
    3. Felemban SM,
    4. Stephens GM,
    5. Al-Hakeem RF,
    6. Zumla AI,
    7. et al.

    (2012) HIV case notification rates in the Kingdom of Saudi Arabia over the past decade (2000-2009). PLoS One 7:e45919.

    OpenUrlPubMed
16. ↵
    1. Mehdi SR,
    2. Pophali A,
    3. Al-Abdul Rahim KA

    (2000) Prevalence of hepatitis B and C and blood donors. Saudi Med J 21:942–944.

    OpenUrlPubMed
17. 1. El-Hazmi MM

    (2004) Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 25:26–33.

    OpenUrlPubMedWeb of Science
18. 1. Madani TA

    (2007) Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance. Ann Saudi Med 27:191–194.

    OpenUrlPubMed
19. ↵
    1. Abdo AA,
    2. Sanai FM,
    3. Al-Faleh FZ

    (2012) Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook? Saudi J Gastroenterol 18:349–357.

    OpenUrlCrossRefPubMed
20. ↵
    1. Bashawri LA,
    2. Fawaz NA,
    3. Ahmad MS,
    4. Qadi AA,
    5. Almawi WY

    (2004) Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 26:225–228.

    OpenUrlCrossRefPubMed
21. ↵
    1. Madani TA

    (2007) Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. Trans R Soc Trop Med Hyg 101:278–283.

    OpenUrlCrossRefPubMed
22. ↵
    1. Al-Faleh F

    (1988) Hepatitis B infection in Saudi Arabia. Ann Saudi Med 8:474–480.

    OpenUrlWeb of Science
23. ↵
    1. Al-Faleh F

    (2003) Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med 23:367–371.

    OpenUrlPubMed